AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN MutationsBusiness Wire • 04/15/24
Will FTD Companies (FTD) Report Negative Q1 Earnings? What You Should KnowZacks Investment Research • 05/07/19
FTD Companies, Inc. (FTD) CEO Scott Levin on Q4 2018 Results - Earnings Call TranscriptSeeking Alpha • 03/14/19